Autism 'Cure' Products Spur Comment Wave On FDA's VMS Industry Oversight
More than half the 73 comments posted to FDA's DSHEA modernization docket are from consumers concerned about a specific type of product, bleach-containing liquids marketed as a cure for autism.
You may also be interested in...
FDA says it "recently received new" AERs linked to products as it repeats a warning initially made in 2010 about dangers of products marketed as "Miracle Mineral Solution," "Miracle Mineral Supplement," "MMS," "Chlorine Dioxide (CD) Protocol," "Water Purification Solution (WPS)" and with similar brand names.
FDA's notice for a May 16 public meeting say it intends to ensure its "regulatory framework is flexible enough to adequately evaluate product safety without unnecessarily restricting innovation." But FDA makes clear adherence with its NDI notification requirement is focus of the spurring improvement in VMS product industry's overall compliance with regulatory framework established by DSHEA.
"The difficult truth that we need to face," says Eric Pierce, New Hope Network's strategy and insights director, is that most consumers don't trust the supplement industry.